Fig. 1From: Diagnostic and prognostic performance to detect Alzheimer’s disease and clinical progression of a novel assay for plasma p-tau217Overview of the antibodies used in the 2 plasma p-tau217 assays. Plasma p-tau217+Janssen uses a single molecule array (Simoa) and the + highlights that PT3 binding requires phosphorylation at aa217 and is enhanced from additional phosphorylation at aa212. Plasma p-tau217Lilly uses the Meso Scale Discovery (MSD) platformBack to article page